Key Advantages to partner with Samsung Biologics
Samsung Biologics is a trusted partner for seamless tech transfers, clinical and commercial biologics manufacturing, and aseptic fill-finish. In a rapidly evolving biopharmaceutical landscape, identifying a partner that can adapt to the unique needs of each portfolio is essential for success. Samsung Biologics is committed to supporting clients with a wide range of benefits, including unparalleled quality, scalable capacity, process agility, partnership flexibility, operational efficiency, industry-leading sustainability, and continuous innovation.
Samsung Biologics offers advanced CGMP facilities, providing safe and reliable clinical and commercial biologics. All processes are CGMP-compliant and meet the standards defined by regulatory authorities.
Dedicated To Your Unique Needs
From the start of our partnership, you will have a dedicated project management team to guide you through every step of the manufacturing process. We specialize in handling complex molecules, including mAbs, bsAbs/multispecifics, ADCs, recombinant proteins, mRNAs, and Fc fusion proteins. Our commitment to operational excellence in biologics manufacturing and quality ensures that we deliver valuable results.
-
- Drug Substance
- Rising competition requires biological drug developers to take a systematic, cost-effective approach to manufacturing. Samsung Biologics achieves fast turnaround times with an economy of scale to quickly deliver high-quality products to the market.
-
- Drug Product
- Aseptic fill and finish are vital in drug manufacturing to ensure both patient safety and product integrity. Samsung Biologics offers clinical and commercial fill-finish services designed to meet the highest-quality standards, ensuring reliable and safe outcomes.
Trusted CDMO for Your Success
Samsung Biologics evolves with the dynamic biomanufacturing industry. As industry demands grow, we strategically expand our capacity and integrate advanced technologies to tackle the complexities of advanced molecules. Powered by digitalization and AI, we offer enhanced flexibility and innovative solutions to meet your specific needs. Partner with Samsung Biologics, where cutting-edge and unwavering reliability drive your success in biomanufacturing.
- Total capacity in 2025
- 784 kL
-
BIO Campus I
604 kL
+
-
Plant 5
180 kL
BIO Campus I
- Total Capacity
- 604,000 L
- Plant 1
- 30,000 L
- Plant 2
- 154,000 L
- Plant 3
- 180,000 L
- Plant 4
- 240,000 L
- Plant 5
- 180,000 L
- Plant 6-8
- 540,000 L*
*Total capacity by 2032
BIO Campus II
- Plant 5-8
- 720,000 L*
*Total capacity by 2032
-
-
Consecutive years
to be recognized by the
CDMO Leadership Awards
-
- +
-
Regulatory approvals
(FDA, EMA, PMDA, etc.)
(As of March 2025)
